Laurion Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.8K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $473K | Sell |
|
|||||
|
2023
Q3 | $1.34M | Sell |
|
|||||
|
2023
Q2 | $2.77M | Sell |
|
|||||
|
2023
Q1 | $3.57M | Hold |
|
|||||
|
2022
Q4 | $2.78M | Hold |
|
|||||
|
2022
Q3 | $2.69M | Sell |
|
|||||
|
2022
Q2 | $3.83M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $11K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $472K | Buy |
|